Unraveling the heterogeneity in Alzheimer's disease progression across multiple cohorts and the implications for data‐driven disease modeling
Open Access
- 9 June 2021
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 18 (2), 251-261
- https://doi.org/10.1002/alz.12387
Abstract
Introduction Given study-specific inclusion and exclusion criteria, Alzheimer's disease (AD) cohort studies effectively sample from different statistical distributions. This heterogeneity can propagate into cohort-specific signals and subsequently bias data-driven investigations of disease progression patterns. Methods We built multi-state models for six independent AD cohort datasets to statistically compare disease progression patterns across them. Additionally, we propose a novel method for clustering cohorts with regard to their progression signals. Results We identified significant differences in progression patterns across cohorts. Models trained on cohort data learned cohort-specific effects that bias their estimations. We demonstrated how six cohorts relate to each other regarding their disease progression. Discussion Heterogeneity in cohort datasets impedes the reproducibility of data-driven results and validation of progression models generated on single cohorts. To ensure robust scientific insights, it is advisable to externally validate results in independent cohort datasets. The proposed clustering assesses the comparability of cohorts in an unbiased, data-driven manner.This publication has 30 references indexed in Scilit:
- The interactive effect of demographic and clinical factors on hippocampal volume: A multicohort study on 1958 cognitively normal individualsHippocampus, 2017
- Defeating Alzheimer's disease and other dementias: a priority for European science and societyThe Lancet Neurology, 2016
- Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort studyThe Lancet Neurology, 2015
- Meta-analysis of modifiable risk factors for Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2015
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkersThe Lancet Neurology, 2013
- Comparison of Imaging Biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of AgingArchives of Neurology, 2012
- Testing the Right Target and Right Drug at the Right StageScience Translational Medicine, 2011
- Multi-State Models for Panel Data: ThemsmPackage forRJournal of Statistical Software, 2011
- The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's diseaseInternational Psychogeriatrics, 2009
- Age at onset of Alzheimer's diseaseNeurology, 1994